Gisela Lorente

Chief Executive Officer at Aptadel Therapeutics

Gisela Lorente is currently the Chief Executive Officer at Aptadel Therapeutics, having previously held roles such as Chief Scientific Officer and Acting CEO at the same company. Gisela also serves as the AECC Innova external evaluator at the Asociación Española contra el Cáncer. With a background in biomedicine and molecular biology, Gisela has experience in innovation, technology transfer, business development, and project management within the biomedical research and healthcare innovation sectors. Gisela has also served as a researcher, teacher, and advisory board member in various organizations and institutions.

Links

Previous companies

University of Leeds logo

Timeline

  • Chief Executive Officer

    September 1, 2023 - present

  • CSO / Acting CEO And Co-founder

    January, 2021